Fineline Cube

Follow:
14436 Articles
Roche's Evrysdi 5mg Tablet Gains EU Commission Approval for Spinal Muscular Atrophy
CompanyDrug

Roche’s Evrysdi 5mg Tablet Gains EU Commission Approval for Spinal Muscular Atrophy

Shanghai OPM Biosciences Plans Acqusition of PharmaLegacy Labs for RMB 1.45 Billion
CompanyDeals

Shanghai OPM Biosciences Plans Acqusition of PharmaLegacy Labs for RMB 1.45 Billion

Sunshine Guojian's SSGJ-613 Meets Phase III Endpoints in Acute Gouty Arthritis
CompanyDrug

Sunshine Guojian’s SSGJ-613 Meets Phase III Endpoints in Acute Gouty Arthritis

NHSA Strengthens Pharmaceutical Pricing and Procurement Credit Evaluation Mechanism
Policy / Regulatory

NHSA Strengthens Pharmaceutical Pricing and Procurement Credit Evaluation Mechanism

China Issues Whistleblower Incentives for Drug and Medical Device Safety Violations
Policy / Regulatory

China Issues Whistleblower Incentives for Drug and Medical Device Safety Violations

China's National Health Commission Mandates Labor Pain Management Services Expansion
Policy / Regulatory

China’s National Health Commission Mandates Labor Pain Management Services Expansion

Intragrand Pharma Licenses Lenamilast to Transpire Bio for Global Development
CompanyDeals

Intragrand Pharma Licenses Lenamilast to Transpire Bio for Global Development

Consun Pharma Partners with DP Technology to Accelerate AI-Driven Kidney Disease Drug R&D
CompanyDeals

Consun Pharma Partners with DP Technology to Accelerate AI-Driven Kidney Disease Drug R&D

Innovent Biologics' IBI363 Receives Breakthrough Therapy Designation from CDE
CompanyDrug

Innovent Biologics’ IBI363 Receives Breakthrough Therapy Designation from CDE

BMS Secures NMPA Approval for Reblozyl in Myelodysplastic Syndromes
CompanyDrug

BMS Secures NMPA Approval for Reblozyl in Myelodysplastic Syndromes

Shanghai Pharma Partners with Chugai Pharma China to Enhance Bone Health Products
CompanyDeals

Shanghai Pharma Partners with Chugai Pharma China to Enhance Bone Health Products

Genrix Bio Partners with Cullinan Therapeutics for GR1803 License
CompanyDeals

Genrix Bio Partners with Cullinan Therapeutics for GR1803 License